Shuo Mu

407 total citations
20 papers, 174 citations indexed

About

Shuo Mu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuo Mu has authored 20 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuo Mu's work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Shuo Mu is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Shuo Mu collaborates with scholars based in China, United States and Egypt. Shuo Mu's co-authors include Ming Lei, Dong Dong, Yi-Hsuan Pan, Shuyi Zhang, Guantao Zheng, Erli Pang, Kui Lin, Gung‐Wei Chirn, Kai Wang and Mitesh J. Borad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Shuo Mu

16 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Mu China 6 71 55 51 38 34 20 174
Sayed Obaidullah Aseem United States 8 75 1.1× 71 1.3× 19 0.4× 48 1.3× 71 2.1× 21 309
Christoph Eckert Germany 11 144 2.0× 20 0.4× 106 2.1× 13 0.3× 46 1.4× 20 359
Nicole Stowell United States 9 79 1.1× 34 0.6× 60 1.2× 17 0.4× 15 0.4× 14 333
Mark A. Taylor United States 11 125 1.8× 45 0.8× 20 0.4× 12 0.3× 14 0.4× 20 377
Takako Serizawa Japan 11 112 1.6× 14 0.3× 93 1.8× 39 1.0× 146 4.3× 17 382
Annika E. Langeneckert Germany 10 33 0.5× 19 0.3× 31 0.6× 16 0.4× 27 0.8× 13 307
Ajeet P. Singh United States 11 240 3.4× 9 0.2× 30 0.6× 55 1.4× 37 1.1× 18 374
John S. Quick United States 5 60 0.8× 11 0.2× 33 0.6× 27 0.7× 23 0.7× 5 172
Yiqi Zhou United States 7 350 4.9× 21 0.4× 27 0.5× 122 3.2× 12 0.4× 10 470
J.F. Michiels France 9 103 1.5× 7 0.1× 37 0.7× 25 0.7× 34 1.0× 17 299

Countries citing papers authored by Shuo Mu

Since Specialization
Citations

This map shows the geographic impact of Shuo Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Mu more than expected).

Fields of papers citing papers by Shuo Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Mu. The network helps show where Shuo Mu may publish in the future.

Co-authorship network of co-authors of Shuo Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Mu. A scholar is included among the top collaborators of Shuo Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Mu. Shuo Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Wenqi, et al.. (2025). Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence. Clinical Pharmacology & Therapeutics. 119(2). 336–349.
2.
3.
4.
5.
Yang, Haijun, Yong Cheng, Yiyang Zhao, et al.. (2024). Exercise combing with short-term continuous glucose monitoring promotes diabetes health self-care scale and glycemic control in individuals with type 2 diabetes. Science & Sports. 39(5-6). 483–488. 1 indexed citations
6.
Javle, Milind, Fei Pang, Zhao Wei, et al.. (2019). Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients. HepatoBiliary Surgery and Nutrition. 8(6). 604–614. 36 indexed citations
7.
Stradella, Agostina, Melissa L. Johnson, Sanjay Goel, et al.. (2019). Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (ld) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumours. Annals of Oncology. 30. v166–v167. 1 indexed citations
8.
Jia, Wei, Fangfang Zhong, Weifeng Wang, et al.. (2019). Effect of exonic microsatellite instability of B2M on the predictability of MSI/dMMR for immunotherapy.. Journal of Clinical Oncology. 37(15_suppl). 2576–2576. 1 indexed citations
9.
Zhang, Sen, Yun Guo, Hui Li, et al.. (2018). Abstract 4613: The difference of molecular signatures in left- and right-sided colorectal cancer Chinese patients. Cancer Research. 78(13_Supplement). 4613–4613. 9 indexed citations
10.
Johnson, Melissa L., Matt D. Galsky, Minal Barve, et al.. (2018). Preliminary results of pamiparib (BGB-290), a PARP1/2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumors. Annals of Oncology. 29. viii138–viii138. 2 indexed citations
11.
Gao, Jing, Wenwen Huang, Shuo Mu, et al.. (2018). The pathway regulating RhoA activity to predict the survival of gastric cancers.. Journal of Clinical Oncology. 36(4_suppl). 49–49. 1 indexed citations
12.
Gu, Weiguang, Yong Li, Bai Liu, et al.. (2018). Circulating tumor DNA analysis for osimertinib resistance Chinese NSCLC patients.. Journal of Clinical Oncology. 36(15_suppl). e24061–e24061.
13.
Jia, Jun, Peng Zhang, Wenjing Liu, et al.. (2018). Correlation of tumor mutational burden and predicted functional impact of mutations across cancer types.. Journal of Clinical Oncology. 36(15_suppl). e24296–e24296. 1 indexed citations
14.
Ali, Siraj M., Ming Yao, Jicheng Yao, et al.. (2017). Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy. Cancer. 123(18). 3628–3637. 36 indexed citations
15.
Mu, Shuo, Hu Zhang, Jian Hu, et al.. (2017). Analytical and clinical validation of a next-generation sequencing-based circulating tumor DNA (ctDNA) assay assures its clinical application. Annals of Oncology. 28. v450–v450. 3 indexed citations
16.
Hu, Jian, Mengcen Wang, Lei Dai, et al.. (2017). P1.07-038 The Potential Clinical Application of Comprehensive Genomic Profiling in Targeted Therapy and Immunotherapy of Lung Cancer. Journal of Thoracic Oncology. 12(11). S2010–S2010. 1 indexed citations
17.
Dong, Dong, Ming Lei, Yi-Hsuan Pan, et al.. (2016). The Genomes of Two Bat Species with Long Constant Frequency Echolocation Calls. Molecular Biology and Evolution. 34(1). 20–34. 33 indexed citations
18.
Wang, Xuan, et al.. (2015). BGD: A Database of Bat Genomes. PLoS ONE. 10(6). e0131296–e0131296. 2 indexed citations
19.
Lei, Ming, Dong Dong, Shuo Mu, Yi-Hsuan Pan, & Shuyi Zhang. (2014). Comparison of Brain Transcriptome of the Greater Horseshoe Bats (Rhinolophus ferrumequinum) in Active and Torpid Episodes. PLoS ONE. 9(9). e107746–e107746. 36 indexed citations
20.
Xiong, You‐Cai, Hongfang Wang, Xiaohua Wu, et al.. (2008). [Genetic diversity of Hippophae rhamnoides L. sub-populations on loess plateau under effects of varying meteorologic conditions].. PubMed. 19(1). 1–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayed Obaidullah Aseem Breakdown of academic impact, for papers by Christoph Eckert Breakdown of academic impact, for papers by Nicole Stowell Breakdown of academic impact, for papers by Mark A. Taylor Breakdown of academic impact, for papers by Takako Serizawa Breakdown of academic impact, for papers by Annika E. Langeneckert Breakdown of academic impact, for papers by Ajeet P. Singh Breakdown of academic impact, for papers by John S. Quick Breakdown of academic impact, for papers by Yiqi Zhou Breakdown of academic impact, for papers by J.F. Michiels
Rankless by CCL
2026